🇺🇸 FDA
Company

ROCKET

ROCKET PHARMACEUTICALS, INC.

RCKT pharma USA

Quick answer

ROCKET is a pharma company (RCKT) headquartered in NEW YORK, NY, USA with 11 tracked pipeline programs.

Pipeline (11)

project

RP-A501

Danon Disease

Phase 2 · gene_therapy · active

2 trials project

RP-L102

Fanconi Anemia Complementation Group A

Phase 2 · mab · active

3 trials project

RP-L201

Leukocyte Adhesion Defect - Type I

Phase 2 · mab · completed

2 trials project

RP-L301

Pyruvate Kinase Deficiency

Phase 2 · mab · on_hold

2 trials project

Filgrastim

Fanconi Anemia

Phase 1 · mab · terminated

1 trials project

RP-A601

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Phase 1 · gene_therapy · active

1 trials project

RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3)

Dilated Cardiomyopathy (DCM)

Phase 1 · gene_therapy · active

1 trials project

RP-L401

Infantile Malignant Osteopetrosis

Phase 1 · mab · terminated

1 trials project

SIS-reinforced anastomosis

Rectal Cancer

Approved · other · active

1 trials project

Xuebijing

Pulmonary Disease, Chronic Obstructive

Approved · small_molecule · active

1 trials project

Clostridium butyricum (live) Tablets(Meiya)

Rectal Cancer

Unknown · mab · active

1 trials

Patents (1)

patent

US 10703797

Gene therapy vectors for treatment of Danon disease

Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)